Characteristics of treatment naïve chronic hepatitis B in Bangladesh: younger populations are more affected; HBeAg-negatives are more advanced
- PMID: 19568488
- PMCID: PMC2702890
- DOI: 10.4103/1319-3767.37796
Characteristics of treatment naïve chronic hepatitis B in Bangladesh: younger populations are more affected; HBeAg-negatives are more advanced
Abstract
Background/aim: Bangladesh is a densely populated country with intermediate endemicity for chronic hepatitis B (CHB). The aim of the present study was to evaluate the biochemical, virological and histological character of CHB patients and to examine the relationship between these indices.
Materials and methods: One thousand and twenty-two patients of CHB fulfilled our inclusion criteria. Inclusion criteria were (1) HBsAg positive for at least 6 months, (2) HBeAg-positive or negative and (3) hepatitis B virus (HBV) DNA positive. Patients with detectable antibodies to human immunodeficiency virus (HIV), hepatitis Delta virus (HDV) or hepatitis C virus (HCV), with previous antiviral treatment, overt cirrhosis and hepatocellular carcinoma, were excluded. Of these, 191 patients were randomly selected for liver biopsy and were evaluated for analysis.
Results: In the 191 patients, male to female ratio was 4.6:1; age distribution was 26.5 +/- 8.5 (mean +/- standard deviation) years. One hundred and seventy-eight (93.2%) patients were under 40 years. Sixty-eight (35.6%) patients were HBeAg-negative, had less DNA load, and were significantly older, more fibrotic and cirrhotic (P < 0.001). Correlation was not found between DNA level and histological activity. Histological activity was not correlated with ALT level in HBeAg-positive patients (P < 0.001).
Conclusion: CHB affects the younger population in Bangladesh. HBeAg-positive CHB was associated with more fibrosis and cirrhosis. Serum HBV DNA levels do not correlate with the severity of histological lesions in all patients. Evaluation by liver biopsy remains gold standard for taking decision of treatment.
Keywords: Age; Bangladesh; chronic hepatitis B.
Conflict of interest statement
Similar articles
-
e-antigen-negative chronic hepatitis B in Bangladesh.Hepatobiliary Pancreat Dis Int. 2008 Aug;7(4):379-82. Hepatobiliary Pancreat Dis Int. 2008. PMID: 18693173
-
Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.Clin Res Hepatol Gastroenterol. 2017 Dec;41(6):635-643. doi: 10.1016/j.clinre.2017.03.004. Epub 2017 Apr 21. Clin Res Hepatol Gastroenterol. 2017. PMID: 28438570
-
Management of chronic hepatitis B.Evid Rep Technol Assess (Full Rep). 2008 Oct;(174):1-671. Evid Rep Technol Assess (Full Rep). 2008. PMID: 19408969 Free PMC article. Review.
-
Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2125-2129. doi: 10.22034/APJCP.2018.19.8.2125. Asian Pac J Cancer Prev. 2018. PMID: 30139211 Free PMC article.
-
Treatment of chronic hepatitis B: case selection and duration of therapy.J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. doi: 10.1046/j.1440-1746.2002.02767.x. J Gastroenterol Hepatol. 2002. PMID: 11982721 Review.
Cited by
-
Hepatitis B Core Antigen in Hepatocytes of Chronic Hepatitis B: Comparison between Indirect Immunofluorescence and Immunoperoxidase Method.Euroasian J Hepatogastroenterol. 2015 Jan-Jun;5(1):7-10. doi: 10.5005/jp-journals-10018-1120. Epub 2015 Jan 6. Euroasian J Hepatogastroenterol. 2015. PMID: 29201677 Free PMC article.
-
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2021 Feb;6(2):106-119. doi: 10.1016/S2468-1253(20)30307-1. Epub 2020 Nov 14. Lancet Gastroenterol Hepatol. 2021. PMID: 33197397 Free PMC article.
References
-
- Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107. - PubMed
-
- Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191–211. - PubMed
-
- McMahon BJ. Hepatocellular carcinoma and viral hepatitis. In: Wilson RA, editor. Viral hepatitis. New York: Marcel Dekker; 1997. pp. 315–30.
-
- Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study. Hepatology. 1988;8:493–6. - PubMed
LinkOut - more resources
Full Text Sources